日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Low awareness of MASLD among U.S. adults: Trends from NHANES 2017-2023

美国成年人对MASLD的认知度较低:来自NHANES 2017-2023年的趋势

Alp, Jameel; Sripongpun, Pimsiri; Roldan, Giovanni A; Fletcher, Jesse A; Davie, Timothy; Udompap, Prowpanga

Characteristics and long-term mortality of individuals with MASLD, MetALD, and ALD, and the utility of SAFE score

MASLD、MetALD 和 ALD 患者的特征和长期死亡率,以及 SAFE 评分的实用性

Sripongpun, Pimsiri; Kaewdech, Apichat; Udompap, Prowpanga; Kim, W Ray

Affordability of Antiviral Therapy in Asia-Pacific Countries and Its Impact on Public Health Outcomes

亚太地区国家抗病毒疗法的可负担性及其对公共卫生结果的影响

Udompap, Prowpanga; Tanwandee, Tawesak; Gani, Rino

Decreasing mortality and disease severity in hepatitis C patients awaiting liver transplantation in the United States

美国等待肝移植的丙型肝炎患者的死亡率和疾病严重程度正在降低

Kwong, Allison; Kim, W Ray; Mannalithara, Ajitha; Heo, Nae-Yun; Udompap, Prowpanga; Kim, Donghee

Increasing prevalence of cirrhosis among U.S. adults aware or unaware of their chronic hepatitis C virus infection

美国成年人中,无论是否知晓自身患有慢性丙型肝炎病毒感染,肝硬化的患病率都在上升。

Udompap, Prowpanga; Mannalithara, Ajitha; Heo, Nae-Yun; Kim, Donghee; Kim, W Ray

Current and Future Burden of Chronic Nonmalignant Liver Disease

慢性非恶性肝病的当前和未来负担

Udompap, Prowpanga; Kim, Donghee; Kim, W Ray